MPS Pharmaa Ltd vs TORRENT PHARMACEUTICALS L

A side-by-side comparison of MPS Pharmaa Ltd (531686) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, TORRENT PHARMACEUTICALS L leads 531686 vs TORNTPHARM on 10 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability04
  • Growth· not comparable
  • Size & financial health13

Valuation

TORNTPHARM takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
77.88
53.27
P/B ratio
18.67
0.00%
Dividend yield
0.76%
₹-0.47
EPS
₹63.92

Profitability

TORNTPHARM takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-83.30%
Return on equity
27.40%
-9.79%
Return on capital
15.00%
0.00%
EBITDA margin
33.00%
0.00%
Net margin
15.29%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y) even
13.27%
Profit CAGR (3Y) even
19.75%

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹7 Cr
Market cap
₹1.90L Cr
₹0 Cr
Revenue
₹13,980 Cr
₹-1 Cr
Net profit
₹2,138 Cr
0.00
Debt / equity
1.69
MPS Pharmaa Ltd
  • ["Stock is trading at 54.3 times its book value", "Company has low interest coverage ratio.", "Promoter holding is low: 35.9%", "Company has a low return on equity of -61.4% over last 3 years.", "Company might be capitalizing the interest cost"]
TORRENT PHARMACEUTICALS L
  • + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 20.4 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
MPS Pharmaa Ltd full analysis TORRENT PHARMACEUTICALS L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

531686 vs TORNTPHARM: Share Price, Valuation & Which to Buy | DocStoX